BSPGHAN Council are delighted to announce that BSPGHAN will be offering an Annual Award to recognize a member* who has made a major contribution to paediatric gastroenterology, hepatology or nutrition. The award will be given at the Annual Meeting and is to recognise and celebrate an individual’s accomplishment within their career or recent achievements.
A call for nominations will be advertised on the BSPGHAN website in September each year.
Please download the full details for eligibility, standards, criteria and selection process.
*A Full or Associate member of BSPGHAN for at least 5 years at the time of nomination.
Please remember that Honorary Membership may also be conferred by the Society, at the recommendation of Council, upon distinguished colleagues who have made an outstanding contribution to paediatric gastroenterology, whether they be members of the Society or not. Upon retirement, Full Members may apply in writing to the Convenor to become Honorary Members. Honorary Members are not be required to pay the annual subscription fee and do not have voting rights at the Annual General Meeting nor at Special Meetings.
President of BSPGHAN 18/8/21
Please see updated Guidance from the JCVI
in addition to previous advice
At this time,
- the Pfizer-BioNTech BNT162b2 vaccine is the only vaccine authorised for persons aged 12 to 17 years in the UK
- JCVI advises that all 16 to 17-year-olds should be offered a first dose of Pfizer-BNT162b2 vaccine.
- Persons aged 12 to 15 years with specific underlying health conditions that put them at risk of severe COVID-19, should be offered 2 doses of Pfizer-BNT162b2 vaccine with an interval of 8 weeks between doses.
This currently includes children with severe neuro-disabilities, Down’s Syndrome, underlying conditions resulting in immunosuppression, profound and multiple learning disabilities (PMLD), severe learning disabilities or who are on the learning disability register. Details regarding additional person-groups with underlying health conditions to be offered vaccination will be provided as updates in the Green Book.
Children and young people aged 12 years and over who are household contacts of persons (adults or children) who are immunosuppressed should be offered 2 doses of Pfizer-BNT162b2 vaccine.
The rollout of Covid vaccination in England will be led through primary care. The letter notes: “We recognise that not all eligible 12-15 year olds may be identified through the GP record. Therefore, any approach by parents of children at increased risk should be considered and clinical judgement used around eligibility in line with JCVI advice. In addition, trusts may refer 12-15 year olds for a COVID-19 vaccination if they consider them to be eligible”
Letter to primary care –
FAQs on Vaccination delivery operations
Dr S Protheroe